Atlas 2 -- Foundation models for clinical deployment
Maximilian Alber, Timo Milbich, Alexandra Carpen-Amarie, Stephan Tietz, Jonas Dippel, Lukas Muttenthaler, Beatriz Perez Cancer, Alessandro Benetti, Panos Korfiatis, Elias Eulig, Jérôme Lüscher, Jiasen Wu, Sayed Abid Hashimi, Gabriel Dernbach, Simon Schallenberg, Neelay Shah, Moritz Krügener, Aniruddh Jammoria, Jake Matras, Patrick Duffy, Matt Redlon, Philipp Jurmeister, David Horst, Lukas Ruff, Klaus-Robert Müller, Frederick Klauschen, Andrew Norgan
TL;DR
Atlas 2 advances pathology AI by delivering a 2B-parameter tile-based Vision Transformer trained on 5.5 million histopathology WSIs from three institutions, with distilled variants Atlas 2-B and Atlas 2-S that dramatically reduce compute and inference time. The work comprehensively evaluates on eighty public benchmarks spanning morphology, molecular, and survival prediction, demonstrating state-of-the-art performance, robustness, and efficiency across tasks and datasets. Robustness is explicitly quantified with PathoROB, Plismbench, and Patho-Bench, and distillation achieves substantial gains in practicality for clinical deployment. Collectively, the Atlas 2 family offers scalable, robust, and resource-efficient foundation models that are well-positioned for clinical translation in digital pathology.
Abstract
Pathology foundation models substantially advanced the possibilities in computational pathology -- yet tradeoffs in terms of performance, robustness, and computational requirements remained, which limited their clinical deployment. In this report, we present Atlas 2, Atlas 2-B, and Atlas 2-S, three pathology vision foundation models which bridge these shortcomings by showing state-of-the-art performance in prediction performance, robustness, and resource efficiency in a comprehensive evaluation across eighty public benchmarks. Our models were trained on the largest pathology foundation model dataset to date comprising 5.5 million histopathology whole slide images, collected from three medical institutions Charité - Universtätsmedizin Berlin, LMU Munich, and Mayo Clinic.
